Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Eur J Clin Microbiol Infect Dis ; 40(10): 2191-2198, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-33987804

RESUMEN

Molecular diagnosis on nasopharyngeal swabs (NPS) is the current standard for COVID-19 diagnosis, but saliva may be an alternative specimen to facilitate access to diagnosis. We compared analytic performances, feasibility and acceptability of NPS, saliva, and oral-self sampling swab for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A prospective, multicenter study was conducted in military hospitals in France among adult outpatients attending COVID-19 diagnosis centers or hospitalized patients. For each patient, all samples were obtained and analyzed simultaneously with RT-PCR or transcription-mediated amplification method. Clinical signs, feasibility, and acceptability for each type of sample were collected. A total of 1220 patients were included, corresponding to 1205 NPS and saliva and 771 OS. Compared to NPS, the sensitivity, specificity, and kappa coefficient for tests performed on saliva were 87.8% (95% CI 83.3-92.3), 97.1% (95% CI 96.1-98.1), and 0.84 (95% CI 0.80-0.88). Analytical performances were better in symptomatic patients. Ct values were significantly lower in NPS than saliva. For OS, sensitivity was estimated to be 61.1% (95% CI 52.7-69.4) and Kappa coefficient to be 0.69 (95% CI 0.62-0.76). OS was the technique preferred by the patients (44.3%) before saliva (42.4%) and NPS (13.4%). Instructions were perceived as simple by patients (> 90%) for saliva and OS. Finally, the painful nature was estimated to be 0.9 for OS, on a scale from 0 to 10, and to be 5.3 for NPS. Performances of OS are not sufficient. Saliva is an acceptable alternative to NPS for symptomatic patient but the process required additional steps to fluidize the sample.


Asunto(s)
Prueba de COVID-19/métodos , COVID-19/diagnóstico , Pruebas Diagnósticas de Rutina/métodos , Nasofaringe/virología , SARS-CoV-2/aislamiento & purificación , Saliva/virología , Adulto , COVID-19/virología , Estudios de Factibilidad , Femenino , Francia , Humanos , Masculino , Persona de Mediana Edad , Pacientes Ambulatorios , Estudios Prospectivos , SARS-CoV-2/genética , Adulto Joven
3.
Ann Biol Clin (Paris) ; 70(1): 93-7, 2012.
Artículo en Francés | MEDLINE | ID: mdl-22294142

RESUMEN

Granulocytic sarcoma is a rare tumor composed of immature granulocytic cells. Prognosis is poor. The periosteum is preferentially involved. A peritoneum localization is unusual. We report the case of a 20 years old man without particular previous pathologies, which brutally presented an ascitic syndrome in a context of health impairment state. The laparoscopy showes many white nodules on all the peritoneum. The histologic examination of one of these nodules showed granulocytic sarcoma. The blood and bone marrow cell count are without any anomaly. The treatment consisted of a standard acute myeloid leukaemia's chemotherapy with very good evolution. The rarity of peritoneal chloroma causes a diagnostic problem, especially in the absence of hematologic abnormalities. It must be mentioned in the presence of peritoneal nodules even if the blood count and bone marrow are normal.


Asunto(s)
Neoplasias Peritoneales/diagnóstico , Sarcoma Mieloide/diagnóstico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Humanos , Incidencia , Leucemia Mieloide Aguda/tratamiento farmacológico , Masculino , Neoplasias Peritoneales/tratamiento farmacológico , Neoplasias Peritoneales/epidemiología , Neoplasias Peritoneales/patología , Peritoneo/patología , Sarcoma Mieloide/tratamiento farmacológico , Sarcoma Mieloide/epidemiología , Sarcoma Mieloide/patología , Adulto Joven
5.
Ann Biol Clin (Paris) ; 70(4): 477-9, 2012.
Artículo en Francés | MEDLINE | ID: mdl-22796619

RESUMEN

We report the case of a 64 years-old woman, presenting in our hospital with purpura fulminans due to invasive meningococcal B infection. Biological exams led to the diagnosis of multiple myeloma. This case illustrates the importance of immunosuppression in this hematologic disease and allows us to insist on the prophylactic measures to be implemented.


Asunto(s)
Meningitis Meningocócica/diagnóstico , Mieloma Múltiple/diagnóstico , Infecciones Oportunistas/diagnóstico , Púrpura Fulminante/microbiología , Femenino , Humanos , Huésped Inmunocomprometido , Persona de Mediana Edad , Neisseria meningitidis Serogrupo B , Infecciones Oportunistas/microbiología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda